GlassScriptPhysician profile
Timothy Anton Weber
NPI 1780863704
$8,109.58
in general payments reported to CMS, 2019-2025
55 companies · $898 in 2025
The $898 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $2,013 · 2021: $1,198 · 2022: $1,197 · 2023: $1,141 · 2024: $1,123 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.23 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $1,500.00 | 2020 | |
| Axonics, INC. | $708.62 | 2020-2024 | Bulkamid, Axonics |
| Astellas Pharma US INC | $602.70 | 2019-2023 | Myrbetriq, Xtandi |
| Endo Pharmaceuticals INC. | $565.08 | 2019-2023 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $342.61 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $328.87 | 2022-2024 | Aquabeam System |
| Coloplast Corp | $324.68 | 2019-2024 | Titan |
| Ferring Pharmaceuticals INC. | $306.14 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $287.41 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $274.25 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $246.24 | 2023-2024 | Urolift |
| Pfizer INC. | $184.53 | 2020-2025 | |
| Urogen Pharma, INC. | $178.01 | 2022-2025 | Jelmyto |
| Medtronic, INC. | $151.55 | 2022-2023 | Interstim |
| Stryker Corporation | $137.31 | 2023-2024 | Actishield, Viaflow |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $133.73 | 2021-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $133.03 | 2021-2025 | Provenge |
| Blue Earth Diagnostics | $120.11 | 2022-2025 | Posluma |
| Abbvie INC. | $117.28 | 2022-2025 | Lupron Depot, Botox |
| Novartis Pharmaceuticals Corporation | $114.37 | 2022-2025 | |
| Medtronic USA, INC. | $97.44 | 2020 | |
| Clarus Therapeutics INC. | $81.10 | 2021 | |
| Merck Sharp & Dohme LLC | $76.35 | 2021-2025 | Keytruda |
| Endo USA, INC. | $75.61 | 2024-2025 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $74.39 | 2021-2022 | |
| Myovant Sciences INC. | $69.62 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $67.95 | 2022-2023 | |
| Urovant Sciences INC | $66.52 | 2022 | |
| Antares Pharma, INC. | $63.33 | 2021-2022 | |
| Civco Medical Instruments | $53.27 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $46.79 | 2023-2025 | |
| Telix Pharmaceuticals | $45.62 | 2023 | Illuccix |
| Metuchen Pharmaceuticals | $45.49 | 2019-2020 | |
| Tolmar, INC. | $43.99 | 2023 | |
| Travere Therapeutics, INC. | $37.04 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $36.64 | 2021 | |
| Becton, Dickinson and Company | $35.69 | 2023 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Rochester Medical Corporation | $28.29 | 2022 | |
| Tempus Ai, INC | $28.28 | 2025 | Xt Cdx |
| Ethicon US, LLC | $26.61 | 2022 | |
| Allergan, INC. | $26.47 | 2021-2022 | |
| Bluewind Medical | $24.85 | 2025 | |
| Isoray, INC | $23.28 | 2023 | Brachytherapy Source |
| Caldera Medical, INC | $23.11 | 2023 | Desara |
| Ambu INC. | $22.89 | 2021 | |
| Therapeuticsmd, INC. | $17.69 | 2019 | |
| Angiodynamics, INC. | $17.00 | 2024 | Nanoknife |
| Olympus America INC. | $16.54 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.92 | 2022 | |
| Calyxo, INC. | $15.28 | 2025 | Cvac Aspiration System |
| Mimedx Group, INC. | $14.99 | 2025 | |
| Karl Storz Endoscopy-America | $12.44 | 2019 | |
| Amgen INC. | $11.90 | 2019 | |
| Rigicon,INC. | $10.68 | 2023 | Rigi10 Malleable Penile Prosthesis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.